|
PENN Medicine News: Penn Scientists Map Molecular Regulation of Fat-Cell Genetics (University of Pennsylvania Health System)
PHILADELPHIA – A research team led by Mitchell Lazar , MD, PhD , Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine , has used state-of-the-art genetic technology to map thousands of positions where a molecular “master regulator” of fat-cell biology is nestled in DNA to control genes in these cells.
(Nov 4, 2008)
Torrey Path Announces Three New Content Packs for 2009 (Business Wire via Yahoo! Finance)
SAN DIEGO----Torrey Path is pleased to announce the scheduled release of three new content packs, for 2009 – Metabolic Content Pack, Cardiovascular Content Pack, and Neurology Content Pack.
(Nov 4, 2008)
Torrey Path Announces Three New Content Packs for 2009 (Centre Daily Times)
Torrey Path is pleased to announce the scheduled release of three new content packs, for 2009 - Metabolic Content Pack, Cardiovascular Content Pack, and Neurology Content Pack. Content Packs are deep dives into microarray data in specific therapeutic areas. They provide hand-annotated experimental data, discipline-specific controlled vocabulary groups, and a variety of pre-computed ...
(Nov 4, 2008)
Penn scientists map molecular regulation of fat-cell genetics (EurekAlert!)
A research team led by Mitchell Lazar, M.D., Ph.D., Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine, has used state-of-the-art genetic technology to map thousands of positions where a molecular "master regulator" of fat-cell biology is nestled in DNA to control genes in these cells.
(Nov 4, 2008)
AgResearch scientists face job losses (NZPA via Yahoo!Xtra News)
AgResearch are being forced to lay off scientists after an appeal for volunteers for redundancy fell short of the required numbers.
(Nov 4, 2008)
Scientists map molecular regulation of fat-cell genetics (PhysOrg)
A research team led by Mitchell Lazar, MD, PhD, Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine, has used state-of-the-art genetic technology to map thousands of positions where a molecular "master regulator" of fat-cell biology is nestled in DNA to control genes in these cells. The findings appear online this week in Genes & ...
(Nov 4, 2008)
Scientists Map Molecular Regulation of Fat-Cell Genetics (Newswise)
A research team has used state-of-the-art genetic technology to map thousands of positions where a molecular "master regulator" of fat-cell biology is nestled in DNA to control genes in these cells.
(Nov 4, 2008)
NIDCR to Offer $6M in 2009 to Create Craniofacial Genomics Consortium (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Nov 4, 2008)
Invitrogen Provides Update on Merger with Applied Biosystems (wallstreet:online AG)
Invitrogen Corporation (NASDAQ:IVGN) today announced progress against its integration plans regarding
(Nov 4, 2008)
Invitrogen Provides Update on Merger with Applied Biosystems (Centre Daily Times)
Invitrogen Corporation (NASDAQ:IVGN) today announced progress against its integration plans regarding its pending merger with Applied Biosystems.
(Nov 4, 2008)
'Junk' DNA proves functional (EurekAlert!)
In a paper published in Genome Research on Nov. 4, scientists at the Genome Institute of Singapore report that what was previously believed to be "junk" DNA is one of the important ingredients distinguishing humans from other species.
(Nov 4, 2008)
Consumer Not Ready For Tailor Made Nutrition (Medical News Today)
In the near future it will be possible to customise the food we eat to individual needs, based on the genetic profile of the individual. Dutch researcher Amber Ronteltap suggests that the consumer market is not yet ready for this so-called nutrigenomics. Ronteltap concludes that many obstacles must be overcome before products based on nutrigenomics become a reality.
(Nov 5, 2008)
Scientists Map Molecular Regulation Of Fat Cell Genetics (Medical News Today)
A research team led by Mitchell Lazar, MD, PhD, Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine, has used state-of-the-art genetic technology to map thousands of positions where a molecular "master regulator" of fat-cell biology is nestled in DNA to control genes in these cells.
(Nov 5, 2008)
Prolexys Pharmaceuticals Successfully Completes Private Placement of USD 20 Million With Friedli Corporate Finance (Marketwire via Yahoo! Finance)
Prolexys Pharmaceuticals, Inc. has raised $20 million in a Preferred Series A1 round led and managed by Friedli Corporate Finance.
(Nov 5, 2008)
News From BioScience, November 2008 (Medical News Today)
The complete list of research articles in the November 2008 issue of BioScience is as follows: Identifying and Characterizing Bacteria in an Era of Genomics and Proteomics David Emerson, Liane Agulto, Henry Liu, and Liping Liu. New molecular technologies in genomics and proteomics are changing techniques used for identifying bacteria.
(Nov 5, 2008)
Global Drug Discovery Technologies Market to Exceed $57B By 2012, According To A New Report By Global Industry Analysts (DrugDiscoveryOnline)
Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D
(Nov 5, 2008)
Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference (PR Newswire via Yahoo! Finance)
Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics, announced today it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Wednesday, November 10 at The New York Palace Hotel in New York City.
(Nov 5, 2008)
Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference (PR Newswire via Yahoo! Finance)
Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics, announced today it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Wednesday, November 10 at The New York Palace Hotel in New York City.
(Nov 5, 2008)
New therapeutic target identified for rheumatoid arthritis (EurekAlert!)
( Hospital for Special Surgery ) Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. Drugs that hit this new target are actually in trials for the treatment of another disease, leukemia.
(Nov 5, 2008)
Biochemistry Of Human Physiology In Health And Disease Is Focus Of Updated Clinical Text (Medical News Today)
To intelligently perform laboratory methods in the investigation and diagnosis of disease, a solid understanding of the biochemistry behind the diseases and methods is required. The second edition of a leading book that describes the biochemical and physiological fundamentals needed in a clinical setting, Clinical Biochemistry, was recently released by Scion Publishing.
(Nov 5, 2008)
New therapeutic target identified for rheumatoid arthritis (PhysOrg)
Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis.
(Nov 5, 2008)
Penn Scientists Map Molecular Regulation Of Fat-Cell Genetics (BioresearchOnline)
The international obesity epidemic is leading to major health risks, including increased rates of diabetes, heart disease, and cancer. Obesity is caused by increased numbers of fat cells that store more fat than normal. "This research has the potential to lead to new ways to think about therapies aimed at reducing the number of fat cells or altering fat cell function in ways that reduce the ...
(Nov 5, 2008)
Assay Designs(TM), Inc. Announces Agreement with Abnova Corp. of Taiwan (PR Newswire via Yahoo! Finance)
Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life science and translational research markets, has announced a strategic agreement with Abnova Corporation of Taiwan.
(Nov 5, 2008)
Signature Genomic Laboratories Announces Release of Enhanced Microarray for Prenatal Diagnosis (Business Wire via Yahoo! Finance)
SPOKANE, Wash.----Signature Genomic Laboratories announced the release of an enhanced microarray for the prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA.
(Nov 5, 2008)
Personal genomes: A disruptive personality, disrupted (Nature)
Eric Schadt revels in making people uncomfortable with his science. Bryn Nelson reports how the bioinformatics rabble-rouser hopes to charge ahead in the face of his company's disintegration.
(Nov 5, 2008)
Genomics takes hold in Asia (Nature)
Genome Institute of Singapore head Edison Liu talks about how to make pan-Asian genomics research projects work.
(Nov 5, 2008)
How to get the most from a gene test (Nature)
New tools squeeze more research out of personal genomics.
(Nov 5, 2008)
African, Asian join the library of genomics (TODAYonline)
This undated illustration shows the DNA double helix. Laboratories have for the first time sequenced the full genetic code of an African and an Asian in what amounts to a major step towards the goal of a tailor-made profile of one's DNA.
(Nov 5, 2008)
African, Asian join the library of genomics (AFP via Yahoo! News)
Laboratories have for the first time sequenced the full genetic code of an African and an Asian in what amounts to a major step towards the goal of a tailor-made profile of one's DNA.
(Nov 5, 2008)
African, Asian join the library of genomics (AFP via Yahoo!7 News)
PARIS (AFP) - Laboratories have for the first time sequenced the full genetic code of an African and an Asian in what amounts to a major step towards the goal of a tailor-made profile of one's DNA.
(Nov 5, 2008)
African, Asian Join Genomics Library (Discovery Channel)
The full genetic profiles of two men are opening a window on human diversity.
(Nov 5, 2008)
Through the Eye of a Needle - Labcyte Awarded U. S. Patent Describing the Acoustic Transfer of Droplets into Small ... (Business Wire via Yahoo! Finance)
SUNNYVALE, Calif.----Labcyte Inc., the pioneer in ‘touchless’ acoustic transfer of liquids, announces the issuance of U.S. Patent 7,405,395 which exploits the unique advantages of using sound to move liquids.
(Nov 5, 2008)
Through the Eye of a Needle - Labcyte Awarded U. S. Patent Describing the Acoustic Transfer of Droplets into Small ... (Centre Daily Times)
Labcyte Inc., the pioneer in 'touchless' acoustic transfer of liquids, announces the issuance of U.S. Patent 7,405,395 which exploits the unique advantages of using sound to move liquids. This patent describes the acoustic transfer of fluid droplets into openings less than 300 microns in diameter. "We have exquisite capabilities for directing a droplet exactly to where we want it," said Chief ...
(Nov 5, 2008)
Scientists map molecular regulation of fat-cell genetics (News-Medical-Net)
A research team led by Mitchell Lazar, MD, PhD, Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine, has used state-of-the-art genetic technology to map thousands of positions where a molecular "master regulator" of fat-cell biology is nestled in DNA to control genes in these cells.
(Nov 5, 2008)
SurModics Reports Fourth Quarter and Fiscal Year 2008 Results (Business Wire via Yahoo! Finance)
EDEN PRAIRIE, Minn.----SurModics, Inc. , a leading provider of surface modification and drug delivery technologies to the healthcare industry, today reported financial results for the fourth quarter and fiscal year ended September 30, 2008.
(Nov 5, 2008)
Top gong for asthma researcher (The Maitland Mercury)
A Maitland woman who has pioneered a new area of asthma research has received the Hunter Medical Research Institute (HMRI) Awards for early career research.
(Nov 5, 2008)
Proteomics study yields clues as to how tuberculosis might be thwarting the immune system (EurekAlert!)
( DOE/Lawrence Berkeley National Laboratory ) A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Berkeley Lab researchers have discovered proteins residing in both systems that point to "cross-talk" between them.
(Nov 5, 2008)
Proteomics study yields clues as to how tuberculosis might be thwarting the immune system (PhysOrg)
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Scientists with the U.S. Department of Energy's (DOE) Lawrence Berkeley National Laboratory have discovered proteins residing in both systems that point to ...
(Nov 5, 2008)
Personal genomes: The case of the missing heritability (Nature)
When scientists opened up the human genome, they expected to find the genetic components of common traits and diseases. But they were nowhere to be seen. Brendan Maher shines a light on six places where the missing loot could be stashed away.
(Nov 5, 2008)
African, Asian join library of genomics (AAP via Yahoo!7 News)
Laboratories have for the first time sequenced the full genetic code of an African and an Asian in a major step towards tailoring one's DNA.
(Nov 5, 2008)
New Therapeutic Target Identified For Rheumatoid Arthritis (Science Daily)
Researchers have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. Drugs that hit this new target are actually in trials for the treatment of another disease, leukemia.
(Nov 6, 2008)
How Tuberculosis Might Be Thwarting Immune System: Proteomics Study Yields Clues (Science Daily)
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Berkeley Lab researchers have discovered proteins residing in both systems that point to "cross-talk" between them.
(Nov 6, 2008)
Does personalized genomics pit privacy against ethics? (Ars Technica)
As genomic technology becomes available to the public and the cost of sequencing a human genome drops, Nature is hosting a discussion of how privacy and ethics considerations should influence how this newly-developed field is regulated. Read More...
(Nov 6, 2008)
Chinese, African Genomes Sequenced (Technology Review)
By validating an emerging technology, two new genomic studies offer hope for the fight against disease.
(Nov 6, 2008)
QIAGEN and Institute for Animal Health Enter Partnership in Bluetongue Testing (Marketwire via Yahoo! Finance)
Worldwide license agreement expands the Company's veterinary assay portfolio and aims to contain future outbreaks of the devastating viral disease
(Nov 6, 2008)
DJ HUGIN NEWS/QIAGEN and Institute for Animal Health -2- (Financial.de)
Worldwide license agreement expands the Company's veterinary assay portfolio and aims to contain future outbreaks of the devastating viral disease Venlo, The Netherlands - November 6, 2008 - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced today that it has entered into a worldwide exclusive partnership with the Institute for Animal Health (IAH), a leading research and ...
(Nov 6, 2008)
06.11.2008 - DJ HUGIN NEWS/QIAGEN and Institute for Animal Health Enter Partnership in Bluetongue Testing (4investors)
Venlo, The Netherlands - November 6, 2008 - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced today that it has entered into a worldwide exclusive partnership with the Institute for Animal Health (IAH), a leading research and diagnostics institution for infectious diseases of farm animals.
(Nov 6, 2008)
New therapeutic target for inflammatory disorders (News-Medical-Net)
Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis.
(Nov 6, 2008)
New therapeutic target for rheumatoid arthritis identified (New Kerala)
Washington, Nov 6 : Researchers at Hospital for Special Surgery have identified a new therapeutic target that can be used for the treatment of rheumatoid arthritis.
(Nov 6, 2008)
Proteomics provides clues to how tuberculosis thwarts the immune system (News-Medical-Net)
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases.
(Nov 6, 2008)
|
